Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
BACKGROUND: Budesonide/formoterol maintenance and reliever therapy maintains asthma control and reduces exacerbation frequency compared with higher fixed-dose combination regimens. Its effects on eosinophilic airway inflammation and structure are unknown. OBJECTIVE: We sought to compare the effects...
Päätekijät: | Pavord, I, Jeffery, P, Qiu, Y, Zhu, J, Parker, D, Carlsheimer, A, Naya, I, Barnes, N |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2009
|
Samankaltaisia teoksia
-
Controlled trial of budesonide–formoterol as needed for mild asthma
Tekijä: Beasley, R, et al.
Julkaistu: (2019) -
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
Tekijä: Barnes, N, et al.
Julkaistu: (2007) -
COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
Tekijä: V. A. Nikitin, et al.
Julkaistu: (2016-03-01) -
Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
Tekijä: Sergey K. Zyryanov, et al.
Julkaistu: (2022-08-01) -
Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
Tekijä: O'Connor Brian J, et al.
Julkaistu: (2011-12-01)